Tumor progression and metastasis in a genetically engineered mouse model with a mutant c-Myc allele, was associated with transition from SCLC-A to SCLC-N subtype and in a subset of tumors to low-NE Yap1+SCLC [6, 8]. Here, MYC is linked to small cell lung carcinoma.